查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1417249

乾癬性關節炎治療市場報告：2030 年趨勢、預測與競爭分析

Psoriatic Arthritis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

乾癬性關節炎的治療趨勢和預測

至2030年，全球乾癬性關節炎治療市場預計將達到157.7億美元，2024年至2030年的複合年成長率為9.6%。該市場的主要促進因素是老年人口的增加和乾癬性關節炎盛行率的上升，從而增加了對該產品的需求。乾癬性關節炎治療的研究和開發工作正在迅速增加，除了有關乾癬性關節炎治療的知識不斷增加之外，我們還看到大量​​用於銀屑病關節炎的新藥、生物製藥和生物學名藥。為此，研發活動激增。全球乾癬性關節炎治療市場的未來看起來充滿希望，醫院藥房、零售藥房和線上藥房市場充滿機會。

乾癬性關節炎治療市場的見解

Lucintel 預測，由於生物療法在疾病管理方面的有效性，生物治療的使用不斷增加，因此緩解疾病的生物抗風濕藥物將在預測期內實現最高成長。

由於乾癬性關節炎的發生率和學名藥數量的增加，預計亞太地區在預測期內將出現最高的成長。

常問問題

Q.1乾癬性關節炎治療的市場規模有多大：

A1. 到 2030 年，全球乾癬性關節炎治療市場預計將達到 157.7 億美元。

Q.2乾癬性關節炎治療市場的成長預測是多少：

A2. 2024年至2030年，全球乾癬性關節炎治療市場預計將以9.6%的複合年成長率成長。

Q.3 影響乾癬性關節炎治療市場成長的關鍵因素有哪些：

A3. 此市場的主要促進因素是老年人口的增加和乾癬性關節炎盛行率的增加，以及對治療乾癬性關節炎的產品的需求增加。乾癬性關節炎治療的研究和開發工作正在迅速增加，除了有關乾癬性關節炎治療的知識不斷增加之外，我們還看到大量​​用於銀屑病關節炎的新藥、生物製藥和生物學名藥。為此，研發活動激增。

Q4.市場的主要細分市場是：

A4.乾癬性關節炎治療市場的前景看好，醫院藥局、零售藥局和線上藥局市場都有機會。

Q5.市場的主要企業是：

A5. 主要的乾癬性關節炎治療公司如下。

  • F. Hoffmann-La Roche
  • Novartis
  • Amgen
  • Pfizer
  • Johnson &Johnson Services
  • Eli Lilly and Company
  • AstraZeneca
  • Sanofi
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，由於生物療法在疾病管理方面的有效性，生物治療的使用越來越多，因此生物緩解疾病抗風濕藥物將在預測期內實現最高成長。

Q7. 未來五年預計哪些地區的市場成長最大？

A7.由於乾癬性關節炎的發生率和學名藥數量的增加，預計亞太地區在預測期內將出現最高的成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球乾癬性關節炎治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球乾癬性關節炎治療市場趨勢（2018-2023）與預測（2024-2030）
  • 按藥物類別分類的全球乾癬性關節炎治療市場
    • 非類固醇消炎劑
    • 非生物緩解疾病緩解抗風濕藥物
    • 生物緩解疾病緩解抗風濕藥物
    • 其他
  • 按給藥途徑的全球乾癬性關節炎治療市場
    • 口服
    • 胃腸外的
    • 外用
  • 按分銷管道分類的全球乾癬性關節炎治療市場
    • 醫院藥房
    • 零售藥房
    • 網路藥房

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球乾癬性關節炎治療市場（按地區）
  • 北美乾癬性關節炎治療市場
  • 歐洲乾癬性關節炎治療市場
  • 亞太地區乾癬性關節炎治療市場
  • 其他地區乾癬性關節炎治療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按藥物類別分類的全球乾癬性關節炎治療市場成長機會
    • 按給藥途徑的全球乾癬性關節炎治療市場成長機會
    • 全球乾癬性關節炎治療市場成長機會（按分銷管道）
    • 全球乾癬性關節炎治療市場按地區成長機會
  • 全球乾癬性關節炎治療市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球乾癬性關節炎治療市場的產能擴張
    • 全球乾癬性關節炎治療市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • F. Hoffmann-La Roche
  • Novartis
  • Amgen
  • Pfizer
  • Johnson & Johnson Services
  • Eli Lilly and Company
  • AstraZeneca
  • Sanofi
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline
簡介目錄

Psoriatic Arthritis Treatment Trends and Forecast

The future of the global psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets. The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030 with a CAGR of 9.6% from 2024 to 2030. The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.

A more than 150-page report is developed to help in your business decisions.

Psoriatic Arthritis Treatment by Segment

The study includes a forecast for the global psoriatic arthritis treatment by drugs class, route of administration , distribution channel, and region.

Psoriatic Arthritis Treatment Market by Drugs Class [Shipment Analysis by Value from 2018 to 2030]:

  • Non-steroidal Anti-inflammatory Drugs
  • Non-biologic Disease Modifying Anti-Rheumatic Drugs
  • Biologic Disease Modifying Anti-Rheumatic Drugs
  • Others

Psoriatic Arthritis Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Parenteral
  • Topical

Psoriatic Arthritis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Psoriatic Arthritis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Psoriatic Arthritis Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies psoriatic arthritis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the psoriatic arthritis treatment companies profiled in this report include-

  • F. Hoffmann-La Roche
  • Novartis
  • Amgen
  • Pfizer
  • Johnson & Johnson Services
  • Eli Lilly And Company
  • Astrazeneca
  • Sanofi
  • Bristol-Myers Squibb Company
  • Glaxosmithkline

Psoriatic Arthritis Treatment Market Insights

Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.

APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.

Features of the Global Psoriatic Arthritis Treatment Market

Market Size Estimates: Psoriatic arthritis treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Psoriatic arthritis treatment market size by drugs class, route of administration , distribution channel, and region in terms of value ($B).

Regional Analysis: Psoriatic arthritis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drugs class, route of administration , distribution channel, and regions for the psoriatic arthritis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the psoriatic arthritis treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the psoriatic arthritis treatment market size?

Answer: The global psoriatic arthritis treatment market is expected to reach an estimated $15.77 billion by 2030.

Q.2 What is the growth forecast for psoriatic arthritis treatment market?

Answer: The global psoriatic arthritis treatment market is expected to grow with a CAGR of 9.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the psoriatic arthritis treatment market?

Answer: The major drivers for this market are rise in the senior population and psoriatic arthritis prevalence, increase in the demand for goods that treat psoriatic arthritis and a spike in research and development efforts to provide new medications for the condition, and robust pipeline of biologic and biosimilar drugs, as well as increased knowledge of psoriatic arthritis therapy.

Q4. What are the major segments for psoriatic arthritis treatment market?

Answer: The future of the psoriatic arthritis treatment market looks promising with opportunities in the hospital pharmacies, retail pharmacies, and online pharmacies markets.

Q5. Who are the key psoriatic arthritis treatment market companies?

Answer: Some of the key psoriatic arthritis treatment companies are as follows.

  • F. Hoffmann-La Roche
  • Novartis
  • Amgen
  • Pfizer
  • Johnson & Johnson Services
  • Eli Lilly and Company
  • AstraZeneca
  • Sanofi
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline

Q6. Which psoriatic arthritis treatment market segment will be the largest in future?

Answer: Lucintel forecasts that biologic disease modifying anti-rheumatic drugs is expected to witness highest growth over the forecast period due to increasing use of biological treatments as a result of their effectiveness in managing the illness.

Q7. In psoriatic arthritis treatment market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising rates of psoriatic arthritis instances and the quantity of generic medications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the psoriatic arthritis treatment market by drugs class (non-steroidal anti-inflammatory drugs, non-biologic disease modifying anti-rheumatic drugs, biologic disease modifying anti-rheumatic drugs, and others), route of administration (oral, parenteral, and topical), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Psoriatic Arthritis Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Psoriatic Arthritis Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Psoriatic Arthritis Treatment Market by Drugs Class
    • 3.3.1: Non-steroidal Anti-inflammatory Drugs
    • 3.3.2: Non-biologic Disease Modifying Anti-Rheumatic Drugs
    • 3.3.3: Biologic Disease Modifying Anti-Rheumatic Drugs
    • 3.3.4: Others
  • 3.4: Global Psoriatic Arthritis Treatment Market by Route of Administration
    • 3.4.1: Oral
    • 3.4.2: Parenteral
    • 3.4.3: Topical
  • 3.5: Global Psoriatic Arthritis Treatment Market by Distribution Channel
    • 3.5.1: Hospital Pharmacies
    • 3.5.2: Retail Pharmacies
    • 3.5.3: Online Pharmacies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Psoriatic Arthritis Treatment Market by Region
  • 4.2: North American Psoriatic Arthritis Treatment Market
    • 4.2.2: North American Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
  • 4.3: European Psoriatic Arthritis Treatment Market
    • 4.3.1: European Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
    • 4.3.2: European Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
  • 4.4: APAC Psoriatic Arthritis Treatment Market
    • 4.4.1: APAC Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
    • 4.4.2: APAC Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
  • 4.5: ROW Psoriatic Arthritis Treatment Market
    • 4.5.1: ROW Psoriatic Arthritis Treatment Market by Drugs Class: Non-steroidal Anti-inflammatory Drugs, Non-biologic Disease Modifying Anti-Rheumatic Drugs, Biologic Disease Modifying Anti-Rheumatic Drugs, and Others
    • 4.5.2: ROW Psoriatic Arthritis Treatment Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Drugs Class
    • 6.1.2: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Route of Administration
    • 6.1.3: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Psoriatic Arthritis Treatment Market by Region
  • 6.2: Emerging Trends in the Global Psoriatic Arthritis Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Psoriatic Arthritis Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Psoriatic Arthritis Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann-La Roche
  • 7.2: Novartis
  • 7.3: Amgen
  • 7.4: Pfizer
  • 7.5: Johnson & Johnson Services
  • 7.6: Eli Lilly and Company
  • 7.7: AstraZeneca
  • 7.8: Sanofi
  • 7.9: Bristol-Myers Squibb Company
  • 7.10: GlaxoSmithKline